Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery (Q27702294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Yuxi Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Hang Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Yamei Yu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Yangping Wu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Xiangzheng Chen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Qinhuai Lai

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Zhaoya Yang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Qiang Chen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Jinliang Yang

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

language of work or name

English

0 references

publication date

4 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

283

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

102-111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26462166%20AND%20SRC:MED&resulttype=core&format=json

Microtubules and resistance to tubulin-binding agents

27 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Targeting microtubules for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Tubulin modifications and their cellular functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Structure of tubulin at 6.5 A and location of the taxol-binding site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Structural basis for the regulation of tubulin by vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Structural basis of microtubule stabilization by laulimalide and peloruside A

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

An overview of tubulin inhibitors that interact with the colchicine binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

History of the use of colchicum and related medicaments in gout; with suggestions for further research

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Colchicine-binding protein of mammalian brain and its relation to microtubules

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Variations in the colchicine-binding domain provide insight into the structural switch of tubulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Stathmin and Interfacial Microtubule Inhibitors Recognize a Naturally Curved Conformation of Tubulin Dimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Refined structure of alpha beta-tubulin at 3.5 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Phase I, pharmacokinetic and pharmacodynamic evaluation of CYT997, an orally-bioavailable cytotoxic and vascular-disrupting agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Discovery of CYT997: a structurally novel orally active microtubule targeting agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Nocodazole is a High‐Affinity Ligand for the Cancer‐Related Kinases ABL, c‐KIT, BRAF, and MEK

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

A common pharmacophore for a diverse set of colchicine site inhibitors using a structure-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Towards the identification of the binding site of benzimidazoles to β-tubulin of Trichinella spiralis: insights from computational and experimental data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Phase 1 study of the novel vascular disrupting agent plinabulin (NPI-2358) and docetaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Anti-microtubule 'plinabulin' chemical probe KPU-244-B3 labeled both alpha- and beta-tubulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Tivantinib: critical review with a focus on hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Phase 1 dose-escalation trial evaluating the combination of the selective MET (mesenchymal-epithelial transition factor) inhibitor tivantinib (ARQ 197) plus erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Tivantinib (ARQ 197) exhibits antitumor activity by directly interacting with tubulin and overcomes ABC transporter-mediated drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Class III beta-tubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Tubulin-targeted drug action: functional significance of class ii and class IVb beta-tubulin in vinca alkaloid sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

-Tubulin Epitope Expression in Normal and Malignant Epithelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Determination of the optimal tubulin isotype target as a method for the development of individualized cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Multi-target drugs: the trend of drug research and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Stathmin family proteins display specific molecular and tubulin binding properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Molecular mechanism of action of microtubule-stabilizing anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Processing of X-ray diffraction data collected in oscillation mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

Coot: model-building tools for molecular graphics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

PHENIX: building new software for automated crystallographic structure determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555

MolProbity: all-atom structure validation for macromolecular crystallography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.13555